Publications (876)
-
Reply to Martinez-Frias and Rodriguez-Pinilla
Reply to Martinez-Frias and Rodriguez-Pinilla
Bakker M, de Walle H, de Jong-van den Berg L
Birth Defects Research (Part A), 2008 , 82: 175 - 175
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes
Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes
Swamy R, Embleton N, Hale J
Prenatal Diagnosis, 2008 , 28: 1048 - 1051
Subjects: Other, Prenatal Screening & Diagnosis, Prevalence & Perinatal Mortality -
Screening for subtelomeric chromosome alteration in a consecutive series of newborns with congenital defects
Screening for subtelomeric chromosome alteration in a consecutive series of newborns with congenital defects
Rodriguez L, Martinez-Fernandez ML, Mansilla E, Mendioroz J, Arteaga RM, Toral JF, Guardia NM, Garcia A, Centeno F, Pantoja J, Jovani C, Martinez-Frias M-L
Clinical Dysmorphology, 2008 , 17: (1) 5 - 12
Subjects: Genetics and Syndromes -
Space-time analysis of Down syndrome: results consistent with transient pre-disposing contagious agent
Space-time analysis of Down syndrome: results consistent with transient pre-disposing contagious agent
McNally R, Rankin J, Shirley M, Rushton S, Pless-Mulloli T
International Journal of Epidemiology, 2008 , 37: 1169 - 1179
Subjects: Prevention & Risk Factors
Anomalies: Down Syndrome -
Subtelomeric 6p deletion: clinical and array-CGH characterization in two patients
Subtelomeric 6p deletion: clinical and array-CGH characterization in two patients
Martinet D, Filges I, Besuchet Schmutz N, Morris MA, Gaide A-C, Dahoun S, Bottani A, Addor M-C, Antonarakis SE, Beckmann JS, Bena F
American Journal of Medical Genetics Part A, 2008 , 146A: 2094 - 2102
Subjects: Genetics and Syndromes -
Survey of prenatal screening policies in Europe for structure malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome
Survey of prenatal screening policies in Europe for structure malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome
Boyd P, de Vigan C, Khoshnood B, Loane M, Garne E, Dolk H and EUROCAT Working Group
British Journal of Gynaecology, 2008 , 115: 689 - 696
Subjects: Prenatal Screening & Diagnosis
Anomalies: Down Syndrome, Neural Tube Defects -
Ten years after the Dutch public health campaign on folic acid: the continuing challenge
Ten years after the Dutch public health campaign on folic acid: the continuing challenge
de Walle H, de Jong-van den Berg L
European Journal of Clinical Pharmacology, 2008 , 64: 539 - 543
Subjects: Folic Acid -
The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome
The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome
Martinez-Frias M-L
American Journal of Medical Genetics Part A, 2008 , 146A: 1477 - 1482
Subjects: Prevention & Risk Factors
Anomalies: Down Syndrome -
The contribution of late termination of pregnancy to stillbirth rates in Northern England, 1994-2005
The contribution of late termination of pregnancy to stillbirth rates in Northern England, 1994-2005
Bythell M, Bell R, Taylor R, Zalewski S, Wright C, Rankin J, Ward Platt MP
British Journal of Gynaecology, 2008 , 115: 664 - 666
Subjects: Prevalence & Perinatal Mortality -
The hidden mortality of transposition of the great arteries and survival advantage provided by prenatal diagnosis
The hidden mortality of transposition of the great arteries and survival advantage provided by prenatal diagnosis
Blyth M, Howe DT, Gnanapragasam J, Wellesley D
British Journal of Gynaecology, 2008 , 115: 1096 - 1100
Subjects: Prenatal Screening & Diagnosis, Prevalence & Perinatal Mortality
Anomalies: Congenital Heart Anomalies